Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN
Article in American Heart Journal (May 2024)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Article in American Heart Journal (May 2024)
Article in Biomedicines (March 2024)
Article in Progress in Cardiovascular Diseases (March 2024)